pfizer (product)
literal strings: PFIZER, Pfizer, pfizer
categories
NELL has only weak evidence for items listed in grey
- product
- SEAL @122 (50.0%) on 19-jun-2010 [ 1 ] using pfizer
relations
- atdate
- n2005 (99.6%)
- CPL @1095 (99.6%) on 17-jan-2018 [ "arg1 in January of arg2" "arg1 in June arg2" "arg1 in April arg2" "arg1 in December arg2" "arg1 in January arg2" "arg1 in September arg2" "arg1 in February arg2" "arg1 in April of arg2" ] using (pfizer, n2005)
- controlledbyagent
- proxyof
- jeffrey_kindler (100.0%)
NELL has only weak evidence for items listed in grey
- acquiredby
- shell_oil
- CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Chemical and arg2" ] using (shell, pfizer)
- agentcollaborateswithagent
- agentcompeteswithagent
- roche_laboratories
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche_laboratories, pfizer)
- OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp ] using (pfizer, roche_laboratories)
- OE @1104 (96.2%) on 18-mar-2018 [ http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.jnccn.org/content/11/5S/649.abstract http://www.jnccn.org/content/11/5S/649.abstract http://acrabstracts.org/abstract/tocilizumab-combination-therapy-or-monotherapy-or-methotrexate-monotherapy-in-methotrexate-naive-patients-with-early-rheumatoid-arthritis-2-year-clinical-and-radiographic-results-from-a-randomized-p/ http://www.hematology.org/Annual-Meeting/FSS/2945.aspx https://idsa.confex.com/idsa/2007/webprogram/Paper24519.html http://www.uptodate.com/contents/rheumatology/peer-reviewers?topicId=2 http://www.thebody.com/content/art39682.html http://www.hcv-trials.com/faculty-and-disclosure.asp ] using (roche_laboratories, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche_laboratories)
- roche
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (roche, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agenthierarchicallyaboveagent,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcontrols,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:superpartof,concept:agentcontrols,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcollaborateswithagent,concept:agentcompeteswithagent" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:agentcompeteswithagent" ] using (pfizer, roche)
- OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx ] using (roche, pfizer)
- OE @962 (100.0%) on 05-dec-2015 [ http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.fiercepharma.com/story/pfizer-roche-gsk-said-be-knocking-heads-generics-eu-drug-tracking/2012-04-27 http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.pharmatelevision.com/Video/254-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx http://www.forbes.com/sites/matthewherper/2012/05/07/failure-of-roche-hdl-booster-is-bad-news-for-merck-and-eli-lilly/ http://www.bloomberg.com/news/2011-08-19/roche-seeks-6-8-billion-win-on-heart-pill-where-pfizer-failed.html http://www.pharmatelevision.com/Video/247-Panel-Discussion-Panel-discussion--David-Rosen-Pfizer-Robert-Silverman-Roche-Jonathan-Montagu-CoNCERT-Pharmaceuticals.aspx ] using (pfizer, roche)
- agentworkedondrug
- accupril
- SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (accupril, pfizer)
- CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 is manufactured by arg2" ] using (accupril, pfizer)
- aricept
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" ] using (aricept, pfizer)
- SEAL @241 (87.5%) on 22-apr-2011 [ 1 2 3 ] using (aricept, pfizer)
- arimidex
- SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (arimidex, pfizer)
- aromasin
- SEAL @248 (99.6%) on 12-may-2011 [ 1 2 3 4 5 6 7 8 ] using (aromasin, pfizer)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (aromasin, pfizer)
- atorvastatin
- SEAL @878 (100.0%) on 10-oct-2014 [ 1 2 3 ] using (atorvastatin, pfizer)
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 marketed by arg2" "arg1 is currently marketed by arg2" ] using (atorvastatin, pfizer)
- bextra
- SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (bextra, pfizer)
- OE @809 (86.8%) on 01-feb-2014 [ ] using (bextra, pfizer)
- CPL @1094 (100.0%) on 01-jan-2018 [ "arg2 voluntarily withdraw arg1" "arg2 voluntarily removed arg1" "arg2 Celebrex and arg1" "arg2 voluntarily pulled arg1" "arg2 for its promotion of arg1" "arg2 to officially remove arg1" "arg2 to halt sales of arg1" "arg2 promoted the use of arg1" "arg2 has not recalled arg1" "arg2 asked the FDA to approve arg1" "arg2 suspends sales of arg1" "arg2 to voluntarily remove arg1" "arg2 is the company that manufactures arg1" "arg2 voluntarily withdrew arg1" "arg2 suspended sales of arg1" "arg2 to voluntarily withdraw arg1" "arg2 improperly promoted arg1" "arg2 eventually pulled arg1" ] using (bextra, pfizer)
- camptosar
- SEAL @310 (96.9%) on 21-jun-2011 [ 1 2 3 4 5 ] using (camptosar, pfizer)
- cardura
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 was first manufactured by arg2" ] using (cardura, pfizer)
- SEAL @236 (93.8%) on 16-apr-2011 [ 1 2 3 4 ] using (cardura, pfizer)
- casodex
- SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (casodex, pfizer)
- celebrex
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 is marketed by arg2" ] using (celebrex, pfizer)
- SEAL @236 (93.8%) on 16-apr-2011 [ 1 2 3 4 ] using (celebrex, pfizer)
- cetirizine
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (cetirizine, pfizer)
- OE @826 (96.6%) on 28-mar-2014 [ ] using (cetirizine, pfizer)
- champix
- CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 discovered and developed arg1" "arg2 under the trade name arg1" ] using (champix, pfizer)
- SEAL @236 (75.0%) on 16-apr-2011 [ 1 2 ] using (champix, pfizer)
- chantix
- SEAL @209 (87.5%) on 14-feb-2011 [ 1 2 3 ] using (chantix, pfizer)
- CPL @1094 (96.9%) on 01-jan-2018 [ "arg1 was discovered and developed by arg2" "arg1 is marketed by arg2" "arg1 is manufactured by arg2" "arg1 is manufactured and distributed by arg2" "arg1 class action lawsuits against arg2" ] using (chantix, pfizer)
- covera_hs
- SEAL @241 (50.0%) on 22-apr-2011 [ 1 ] using (covera_hs, pfizer)
- crestor
- SEAL @298 (50.0%) on 14-jun-2011 [ 1 ] using (crestor, pfizer)
- cymbalta
- SEAL @275 (50.0%) on 30-may-2011 [ 1 ] using (cymbalta, pfizer)
- depo_provera
- SEAL @263 (100.0%) on 22-may-2011 [ 1 2 3 ] using (depo_provera, pfizer)
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 lawsuit also alleges that arg2" "arg1 is manufactured by arg2" ] using (depo_provera, pfizer)
- diflucan
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (diflucan, pfizer)
- SEAL @224 (99.2%) on 24-mar-2011 [ 1 2 3 4 5 6 7 ] using (diflucan, pfizer)
- effexor
- SEAL @266 (50.0%) on 23-may-2011 [ 1 ] using (effexor, pfizer)
- ellence
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 under the trade name arg1" ] using (ellence, pfizer)
- SEAL @305 (75.0%) on 19-jun-2011 [ 1 2 ] using (ellence, pfizer)
- farmorubicin
- SEAL @269 (100.0%) on 24-may-2011 [ 1 2 3 ] using (farmorubicin, pfizer)
- fluconazole
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (fluconazole, pfizer)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (fluconazole, pfizer)
- fosphenytoin
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (fosphenytoin, pfizer)
- OE @805 (96.8%) on 20-jan-2014 [ ] using (fosphenytoin, pfizer)
- gabapentin
- SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (gabapentin, pfizer)
- geodon
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (geodon, pfizer)
- SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (geodon, pfizer)
- lipitor
- SEAL @224 (98.4%) on 24-mar-2011 [ 1 2 3 4 5 6 ] using (lipitor, pfizer)
- OE @806 (87.6%) on 23-jan-2014 [ ] using (lipitor, pfizer)
- CPL @1094 (99.2%) on 01-jan-2018 [ "arg2 under the trade name arg1" "arg2 continued to market arg1" "arg2 sells as arg1" "arg2 for its marketing of arg1" "arg2 under the brand name arg1" "arg2 could begin to market arg1" "arg2 conducted a study comparing arg1" ] using (lipitor, pfizer)
- metformin
- SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (metformin, pfizer)
- methotrexate
- SEAL @523 (100.0%) on 02-mar-2012 [ 1 2 3 ] using (methotrexate, pfizer)
- neurontin
- SEAL @236 (87.5%) on 16-apr-2011 [ 1 2 3 ] using (neurontin, pfizer)
- CPL @1094 (99.8%) on 01-jan-2018 [ "arg2 fraudulently marketed arg1" "arg2 illegally promoted arg1" "arg2 epilepsy drug arg1" "arg2 had marketed arg1" "arg2 under the brand name arg1" "arg2 is currently marketing arg1" "arg2 promoted the use of arg1" "arg2 received approval for arg1" "arg2 illegally marketed arg1" ] using (neurontin, pfizer)
- norvasc
- CPL @1094 (96.9%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 owns the patent to arg1" "arg2 blood pressure treatment arg1" "arg2 patent protection on arg1" "arg2 under the trade name arg1" ] using (norvasc, pfizer)
- SEAL @221 (96.9%) on 18-mar-2011 [ 1 2 3 4 5 ] using (norvasc, pfizer)
- provera
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 was first manufactured by arg2" ] using (provera, pfizer)
- SEAL @263 (75.0%) on 22-may-2011 [ 1 2 ] using (provera, pfizer)
- rapamune
- SEAL @250 (50.0%) on 14-may-2011 [ 1 ] using (rapamune, pfizer)
- relpax
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (relpax, pfizer)
- SEAL @236 (50.0%) on 16-apr-2011 [ 1 ] using (relpax, pfizer)
- sinequan
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name of arg1" "arg2 under the brand name arg1" ] using (sinequan, pfizer)
- SEAL @241 (75.0%) on 22-apr-2011 [ 1 2 ] using (sinequan, pfizer)
- spiriva
- CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 is made jointly by arg2" ] using (spiriva, pfizer)
- sutent
- SEAL @209 (99.2%) on 14-feb-2011 [ 1 2 3 4 5 6 7 ] using (sutent, pfizer)
- CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 is marketed by arg2" "arg1 is currently marketed by arg2" "arg1 is manufactured by arg2" ] using (sutent, pfizer)
- tenormin
- SEAL @269 (50.0%) on 24-may-2011 [ 1 ] using (tenormin, pfizer)
- topamax
- SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (topamax, pfizer)
- vancomycin
- SEAL @523 (50.0%) on 02-mar-2012 [ 1 ] using (vancomycin, pfizer)
- viagra
- vincristine
- SEAL @263 (50.0%) on 22-may-2011 [ 1 ] using (vincristine, pfizer)
- viracept
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (viracept, pfizer)
- SEAL @241 (87.5%) on 22-apr-2011 [ 1 2 3 ] using (viracept, pfizer)
- zithromax
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 and offered for sale as arg1" ] using (zithromax, pfizer)
- SEAL @224 (93.8%) on 24-mar-2011 [ 1 2 3 4 ] using (zithromax, pfizer)
- zoloft
- CPL @1094 (98.4%) on 01-jan-2018 [ "arg1 is manufactured and marketed by arg2" "arg1 marketed by arg2" "arg1 is being manufactured by arg2" "arg1 which is manufactured by arg2" "arg1 was first manufactured by arg2" "arg1 is manufactured by arg2" ] using (zoloft, pfizer)
- SEAL @221 (96.9%) on 18-mar-2011 [ 1 2 3 4 5 ] using (zoloft, pfizer)
- companyalsoknownas
- sony (biotechcompany)
- CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Electronics and arg2" ] using (sony, pfizer)
- CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Electronics and arg2" ] using (pfizer, sony)
- companyceo
- jeff_kindler
- CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
- SEAL @214 (50.0%) on 22-feb-2011 [ 1 ] using (jeff_kindler, pfizer)
- SEAL @524 (75.0%) on 04-mar-2012 [ 1 2 ] using (jeffrey_b__kindler, pfizer)
- OE @821 (100.0%) on 09-mar-2014 [ ] using (jeff_kindler, pfizer)
- competeswith
- roche_laboratories
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche_laboratories)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche_laboratories, pfizer)
- roche
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (pfizer, roche)
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (pfizer, roche)
- Seed
- OE @803 (99.1%) on 13-jan-2014 [ ] using (roche, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent,concept:proxyfor,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentcontrols,concept:competeswith" "Y~_X0~concept:agentcollaborateswithagent,concept:agentleadsorganization,concept:competeswith" "Y~_X0~concept:worker,concept:proxyfor,concept:competeswith" "Y~_X0~concept:organizationhasperson,concept:proxyfor,concept:competeswith" ] using (roche, pfizer)
- SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ] using (roche, pfizer)
- Seed
- OE @803 (99.1%) on 13-jan-2014 [ ] using (pfizer, roche)
- journal
- CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (pfizer, journal)
- CPL @1109 (50.0%) on 12-jun-2018 [ "arg1 and the Wall Street arg2" ] using (journal, pfizer)
- controlledbyagent
- henry_mckinnell
- OE @823 (100.0%) on 17-mar-2014 [ ] using (henry_mckinnell, pfizer)
- SEAL @359 (99.2%) on 23-jul-2011 [ 1 2 3 4 5 6 7 ] using (henry_mckinnell, pfizer)
- inverseofbacteriaisthecausativeagentofphysiologicalcondition
- plasmodium
- CPL @1104 (75.0%) on 18-mar-2018 [ "arg1 falciparum arg2" "arg1 vivax arg2" ] using (plasmodium, pfizer)
- mutualproxyfor
- henry_mckinnell
- SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (henry_mckinnell, pfizer)
- SEAL @566 (93.8%) on 12-may-2012 [ 1 2 3 4 ] using (pfizer, henry_mckinnell)
- organizationalsoknownas
- sony (biotechcompany)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
- sony (recordlabel)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
- organizationhasagent
- organizationhasperson
- henry_mckinnell
- jeff_kindler
- CPL @1099 (75.0%) on 23-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (jeffrey_b__kindler, pfizer)
- OE @821 (94.5%) on 09-mar-2014 [ ] using (jeff_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhastopmember,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" ] using (jeff_kindler, pfizer)
- OE @961 (100.0%) on 24-nov-2015 [ http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206 ] using (jeffrey_b__kindler, pfizer)
- jeffrey_kindler
- organizationhastopmember
- organizationleadbyperson
- henry_mckinnell
- SEAL @192 (99.8%) on 24-jan-2011 [ 1 2 3 4 5 6 7 8 9 ] using (henry_mckinnell, pfizer)
- OE @823 (100.0%) on 17-mar-2014 [ ] using (henry_mckinnell, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (henry_mckinnell, pfizer)
- jeff_kindler
- CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
- OE @821 (98.8%) on 09-mar-2014 [ ] using (jeff_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeff_kindler, pfizer)
- OE @961 (100.0%) on 24-nov-2015 [ http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206 https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical ] using (jeffrey_b__kindler, pfizer)
- SEAL @302 (99.2%) on 18-jun-2011 [ 1 2 3 4 5 6 7 ] using (jeff_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeffrey_b__kindler, pfizer)
- jeffrey_kindler
- SEAL @563 (93.8%) on 09-may-2012 [ 1 2 3 4 ] using (jeffrey_kindler, pfizer)
- OE @826 (100.0%) on 28-mar-2014 [ ] using (jeffrey_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (jeffrey_kindler, pfizer)
- worker
- henry_mckinnell
- SEAL @521 (87.5%) on 28-feb-2012 [ 1 2 3 ] using (henry_mckinnell, pfizer)
- OE @961 (100.0%) on 24-nov-2015 [ http://www.xconomy.com/san-diego/2013/02/27/optimer-board-ousts-ceo-brings-back-pfizers-mckinnell/ http://www.stern.nyu.edu/experience-stern/news-events/UAT_025918 http://content.time.com/time/specials/packages/article/0,28804,1848501_1848500_1848493,00.html http://www.naturalnews.com/035441_Pfizer_executives_cover-up.html ] using (henry_mckinnell, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (henry_mckinnell, pfizer)
- jeff_kindler
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeff_kindler, pfizer)
- OE @827 (100.0%) on 30-mar-2014 [ ] using (jeff_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeffrey_b__kindler, pfizer)
- OE @961 (100.0%) on 24-nov-2015 [ http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical http://www.reuters.com/article/2010/12/06/us-pfizer-idUSTRE6B50B120101206 https://www.ppdi.com/About/~/link.aspx?_id=3B74933C848E488EAAB78C9BAE6F7F2B&_z=z http://www.businesswire.com/news/home/20090126005624/en/Pfizer-Acquire-Wyeth-Creating-Worlds-Premier-Biopharmaceutical ] using (jeffrey_b__kindler, pfizer)
- CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 is CEO of arg2" "arg1 is Chairman and CEO of arg2" ] using (jeff_kindler, pfizer)
- jeffrey_kindler
- OE @826 (100.0%) on 28-mar-2014 [ ] using (jeffrey_kindler, pfizer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~X0~concept:agentleadsorganization" "Y~X0~concept:agentrepresentsorganization" "Y~X0~concept:personleadsorganization" "Y~X0~concept:personleadsorganization,concept:organizationhasperson,concept:agentleadsorganization" ] using (jeffrey_kindler, pfizer)
- inverseofpersonmovedtostateorprovince
- larry
- CPL @1099 (50.0%) on 23-jan-2018 [ "arg1 Miller of arg2" ] using (larry, pfizer)
- mutualproxyfor
- years (building)
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
- years (emotion)
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (pfizer, years)
- CPL @1112 (50.0%) on 20-jul-2018 [ "arg1 Mexico for four arg2" ] using (years, pfizer)
- new (geopoliticallocation)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- new (politicaloffice)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- new (room)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- new (sportsleague)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- new (tableitem)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- new (traditionalgame)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (new, pfizer)
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 Jersey and arg2" ] using (pfizer, new)
- organizationalsoknownas
- sony (company)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
- sony (publication)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (pfizer, sony)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 Music Entertainment and arg2" ] using (sony, pfizer)
- superpartoforganization
- wyeth
- CPL @1094 (100.0%) on 01-jan-2018 [ "arg1 was bought out by arg2" "arg1 which is now owned by arg2" "arg1 is now a subsidiary of arg2" "arg1 was subsequently acquired by arg2" "arg1 is now owned by arg2" "arg1 was bought by arg2" "arg1 was recently acquired by arg2" "arg1 was acquired by arg2" "arg1 is being acquired by arg2" "arg1 which was acquired by arg2" "arg1 agreed to be acquired by arg2" "arg1 has since been acquired by arg2" ] using (wyeth, pfizer)
- firm
- CPL @1116 (50.0%) on 06-sep-2018 [ "arg1 was acquired by arg2" ] using (firm, pfizer)
- synonymfor
- _
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (_, pfizer)
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is a registered trademark of arg2" ] using (pfizer, _)
- teammate
- mcclain
- CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 and Matt arg2" ] using (pfizer, mcclain)
- CPL @1097 (50.0%) on 19-jan-2018 [ "arg1 and Matt arg2" ] using (mcclain, pfizer)